DK169335B1 - N-((5R,8S,10R)-2,6-dimethyl-ergolin-8-yl)-2-ethyl-2-methyl-butanamid, fremgangsmåde til fremstilling_deraf, farmaceutiske præparater indeholdende forbindelsen samt anvendelse af forbindelsen som farmaceutikum - Google Patents

N-((5R,8S,10R)-2,6-dimethyl-ergolin-8-yl)-2-ethyl-2-methyl-butanamid, fremgangsmåde til fremstilling_deraf, farmaceutiske præparater indeholdende forbindelsen samt anvendelse af forbindelsen som farmaceutikum Download PDF

Info

Publication number
DK169335B1
DK169335B1 DK340188A DK340188A DK169335B1 DK 169335 B1 DK169335 B1 DK 169335B1 DK 340188 A DK340188 A DK 340188A DK 340188 A DK340188 A DK 340188A DK 169335 B1 DK169335 B1 DK 169335B1
Authority
DK
Denmark
Prior art keywords
compound
formula
acid addition
pharmaceutical
addition salt
Prior art date
Application number
DK340188A
Other languages
Danish (da)
English (en)
Other versions
DK340188D0 (da
DK340188A (da
Inventor
Walter Haefliger
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of DK340188D0 publication Critical patent/DK340188D0/da
Publication of DK340188A publication Critical patent/DK340188A/da
Application granted granted Critical
Publication of DK169335B1 publication Critical patent/DK169335B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/10—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hetero atoms directly attached in position 8
    • C07D457/12—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
DK340188A 1987-06-23 1988-06-21 N-((5R,8S,10R)-2,6-dimethyl-ergolin-8-yl)-2-ethyl-2-methyl-butanamid, fremgangsmåde til fremstilling_deraf, farmaceutiske præparater indeholdende forbindelsen samt anvendelse af forbindelsen som farmaceutikum DK169335B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3720656 1987-06-23
DE3720656 1987-06-23

Publications (3)

Publication Number Publication Date
DK340188D0 DK340188D0 (da) 1988-06-21
DK340188A DK340188A (da) 1988-12-24
DK169335B1 true DK169335B1 (da) 1994-10-10

Family

ID=6330087

Family Applications (1)

Application Number Title Priority Date Filing Date
DK340188A DK169335B1 (da) 1987-06-23 1988-06-21 N-((5R,8S,10R)-2,6-dimethyl-ergolin-8-yl)-2-ethyl-2-methyl-butanamid, fremgangsmåde til fremstilling_deraf, farmaceutiske præparater indeholdende forbindelsen samt anvendelse af forbindelsen som farmaceutikum

Country Status (28)

Country Link
US (1) US5075318A (nl)
JP (1) JPH0670052B2 (nl)
KR (1) KR970001527B1 (nl)
AT (1) AT395242B (nl)
AU (1) AU615657B2 (nl)
BE (1) BE1004034A3 (nl)
CA (1) CA1302404C (nl)
CH (1) CH674646A5 (nl)
CY (1) CY1752A (nl)
DK (1) DK169335B1 (nl)
ES (1) ES2010282A6 (nl)
FI (1) FI88302C (nl)
FR (1) FR2617166B1 (nl)
GB (1) GB2206115B (nl)
GR (1) GR1002318B (nl)
HK (1) HK2794A (nl)
HU (2) HU203097B (nl)
IE (1) IE60550B1 (nl)
IL (1) IL86820A (nl)
IT (1) IT1219652B (nl)
LU (1) LU87251A1 (nl)
MY (1) MY103584A (nl)
NL (1) NL8801597A (nl)
NZ (1) NZ225112A (nl)
PH (1) PH24690A (nl)
PT (1) PT87781B (nl)
SE (1) SE467925B (nl)
ZA (1) ZA884505B (nl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL193541C (nl) * 1984-01-12 2000-01-04 Novartis Ag 8 Alfa-acylaminoergolinen, werkwijzen voor de bereiding daarvan en preparaten die ze bevatten.
JP3630888B2 (ja) * 1996-10-31 2005-03-23 株式会社ニデック レンズ搬送装置と眼鏡レンズを搬送するための眼鏡レンズ用固定カップ及びレンズ搬送方法
JP6265583B2 (ja) 2008-10-17 2018-01-24 ウィスコンシン アルムニ リサーチ ファンデイション 生理活性アルファベータペプチドを作製する方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL193541C (nl) * 1984-01-12 2000-01-04 Novartis Ag 8 Alfa-acylaminoergolinen, werkwijzen voor de bereiding daarvan en preparaten die ze bevatten.
CH666035A5 (de) * 1984-12-24 1988-06-30 Sandoz Ag 8-alpha-acylaminoergolene.

Also Published As

Publication number Publication date
HU203097B (en) 1991-05-28
HU211651A9 (en) 1995-12-28
IL86820A (en) 1991-07-18
FI88302C (fi) 1993-04-26
FR2617166A1 (fr) 1988-12-30
CA1302404C (en) 1992-06-02
CY1752A (en) 1994-06-03
DK340188D0 (da) 1988-06-21
ZA884505B (en) 1990-02-28
IL86820A0 (en) 1988-11-30
MY103584A (en) 1993-08-28
GR880100401A (el) 1989-03-08
FR2617166B1 (fr) 1992-07-17
US5075318A (en) 1991-12-24
IE881867L (en) 1988-12-23
FI883008A0 (fi) 1988-06-22
PT87781B (pt) 1992-10-30
BE1004034A3 (fr) 1992-09-15
KR890000479A (ko) 1989-03-14
KR970001527B1 (ko) 1997-02-11
SE8802323L (sv) 1988-12-24
ES2010282A6 (es) 1989-11-01
GR1002318B (el) 1996-05-13
HUT50174A (en) 1989-12-28
IE60550B1 (en) 1994-07-27
IT8848097A0 (it) 1988-06-17
JPS6422876A (en) 1989-01-25
IT1219652B (it) 1990-05-24
SE8802323D0 (sv) 1988-06-21
FI883008A (fi) 1988-12-24
NL8801597A (nl) 1989-01-16
AT395242B (de) 1992-10-27
HK2794A (en) 1994-01-21
DK340188A (da) 1988-12-24
LU87251A1 (fr) 1989-03-08
GB2206115A (en) 1988-12-29
GB8814615D0 (en) 1988-07-27
PH24690A (en) 1990-09-07
GB2206115B (en) 1991-04-03
FI88302B (fi) 1993-01-15
JPH0670052B2 (ja) 1994-09-07
AU1819488A (en) 1989-01-05
SE467925B (sv) 1992-10-05
PT87781A (pt) 1989-05-31
AU615657B2 (en) 1991-10-10
NZ225112A (en) 1991-03-26
CH674646A5 (nl) 1990-06-29
ATA161788A (de) 1992-03-15

Similar Documents

Publication Publication Date Title
AU655075B2 (en) N-alkyl-3-phenyl-3-(2-alkylthiophenoxy)propylamines
US5177112A (en) Substituted 2-aminotetralins
CS227019B2 (en) Method of preparing (-)-n-methyl-3-(2-methylphenyloxy)-3-phenylpropylamine
HU211575A9 (en) 2-methyl-thieno-benzodiazepine
PT85628B (pt) Processo para a preparacao de derivados de piperidina
US20060205770A1 (en) Novel salts of quinuclidine derivative
KR100417506B1 (ko) 항우울 치료를 위한 5ｈｔ1 길항제
ES2204154T3 (es) Ligandos del receptor 5-ht-1 azabiciclicos.
DK169335B1 (da) N-((5R,8S,10R)-2,6-dimethyl-ergolin-8-yl)-2-ethyl-2-methyl-butanamid, fremgangsmåde til fremstilling_deraf, farmaceutiske præparater indeholdende forbindelsen samt anvendelse af forbindelsen som farmaceutikum
IE45149B1 (en) Thienopyridines
JPS6335547A (ja) 置換２−アミノテトラリンおよびその製造方法
CS204036B2 (en) Method of producing novel 4-phenyl-thieno/2,3-c/piperid
FI94860B (fi) Menetelmä terapeuttisesti käyttökelpoisen (+)-1-/(3,4,5-trimetoksi)bentsyylioksimetyyli/-1-fenyyli-N,N-dimetyyli-n-propyyliamiinin valmistamiseksi
HU195491B (en) Process for production of optically active 2-chlor-12-/3-/dimethil-amin/-2-methil-prophil/-12h-dibenzol /d,g/ /1,3,6/-diaxazocine and medical compositions containing such compounds
PT86424B (pt) Processo para a preparacao de tetra-hidropirido-indoles substituidos
SU1083908A3 (ru) Способ получени производных 2-(4-оксиалкил-1-пиперазинил)-2,4,6-циклогептатриен-1-она
KR100222238B1 (ko) 스피로 교상 및 비교상 헤테로고리 화합물
FI89796B (fi) Oxisalicylamidoderivaters mellanprodukter
CS216651B2 (en) Method of making the p-chloracetophenonoxine derivatives
PL157529B1 (en) Method for manufacturing 8 alfa-acyloaminergoline
CS266312B2 (cs) Způsob výroby benzamidových derivátů
MXPA01006669A (en) 5ht1 antagonists for antidepressant therapy

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed